Andrew Knox

Andrew Knox has had extensive work experience in the biotechnology field. Andrew began their career as a Postdoctoral Research Associate at Newcastle University in 2010. Andrew then moved on to Immunocore, where they held various positions including Protein Engineer/Research Scientist, Senior Scientist II, Senior Scientist I, Group Leader in Infectious Diseases, and Disease Area Expert - HBV/Infectious Diseases. During their time at Immunocore, they contributed to the discovery and development of high-affinity TCRs for oncology and successfully delivered a partner molecule into Phase I clinical trials. Andrew joined Molecular Partners in 2020 and currently holds the position of Director - Project Lead/Virology TA Lead. Overall, Andrew's work experience showcases their expertise in TCR-based therapeutics and their leadership in both research and project management roles.

Andrew Knox obtained a Ph.D. in Ribosome Biogenesis from Newcastle University, where they studied from 2007 to 2010. Prior to that, they pursued an MRes Distinction in Functional Genomics at the University of York from 2005 to 2006. Andrew began their academic journey by completing a BSc with First Class honors in Molecular Cell Biology from the University of York, graduating in 2005. Additionally, Andrew attended Reigate College, although the specific details of their degree and field of study are not provided.